The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo

M. S. Grace, T. Lieu, B. Darby, F. C. Abogadie, N. Veldhuis, N. W. Bunnett, P. Mcintyre

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences